title: Matricellular proteins in cardiac adaptation and disease.
abstract: The term matricellular proteins describes a family of structurally unrelated extracellular macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue architecture, but are induced following injury and modulate cell-cell and cell-matrix interactions. When released to the matrix, matricellular proteins associate with growth factors, cytokines, and other bioactive effectors and bind to cell surface receptors transducing signaling cascades. Matricellular proteins are upregulated in the injured and remodeling heart and play an important role in regulation of inflammatory, reparative, fibrotic and angiogenic pathways. Thrombospondin (TSP)-1, -2, and -4 as well as tenascin-C and -X secreted protein acidic and rich in cysteine (SPARC), osteopontin, periostin, and members of the CCN family (including CCN1 and CCN2/connective tissue growth factor) are involved in a variety of cardiac pathophysiological conditions, including myocardial infarction, cardiac hypertrophy and fibrosis, aging-associated myocardial remodeling, myocarditis, diabetic cardiomyopathy, and valvular disease. This review discusses the properties and characteristics of the matricellular proteins and presents our current knowledge on their role in cardiac adaptation and disease. Understanding the role of matricellular proteins in myocardial pathophysiology and identification of the functional domains responsible for their actions may lead to design of peptides with therapeutic potential for patients with heart disease.
authors.affiliation: The Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, 1300 Morris Park Ave., Forchheimer G46B, Bronx, NY 10461, USA. nikolaos.frangogiannis@einstein.yu.edu
authors.forename: Nikolaos G
authors.initials: NG
authors.lastname: Frangogiannis
mesh_terms: D000222:Adaptation, Physiological; D000375:Aging / Q000502:physiology; D000818:Animals; D055511:CCN Intercellular Signaling Proteins / Q000378:metabolism / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006321:Heart / Q000502:physiology / Q000503:physiopathology*; D006331:Heart Diseases / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D008297:Male; D051379:Mice; D053495:Osteopontin / Q000378:metabolism / Q000502:physiology; D051381:Rats; D019063:Tenascin / Q000378:metabolism / Q000502:physiology; D019699:Thrombospondins / Q000378:metabolism / Q000502:physiology; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D055511:CCN Intercellular Signaling Proteins; D016326:Extracellular Matrix Proteins; D019063:Tenascin; D019699:Thrombospondins; D053495:Osteopontin